SHARP PHILLIP A has filed 14 insider transactions across 2 companies since May 2023.
Most recent transaction: a sale of 11250 shares of ALNYLAM PHARMACEUTICALS, INC. ($ALNY) on January 23, 2025.
Activity breakdown: 0 open-market purchases and 7 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SHARP PHILLIP A | Director | S | Common Stock | 11250 | $275.00 | 266,899.0000 | 127,651,000 | 4.04% | 0.01% |
| Jan. 23, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SHARP PHILLIP A | Director | M | Stock Option (right to buy) | 11250 | $0.00 | 0.0000 | 127,651,000 | 100.00% | 0.01% |
| Jan. 23, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SHARP PHILLIP A | Director | M | Common Stock | 11250 | $131.21 | 278,149.0000 | 127,651,000 | 4.22% | 0.01% |
| May 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SHARP PHILLIP A | Director | A | Stock Option (right to buy) | 5228 | $0.00 | 5,228.0000 | 124,906,000 | 9999.99% | 0.00% |
| Feb. 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SHARP PHILLIP A | Director | M | Common Stock | 30000 | $59.25 | 296,899.0000 | 124,906,000 | 11.24% | 0.02% |
| Feb. 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SHARP PHILLIP A | Director | S | Common Stock | 13005 | $150.60 | 283,894.0000 | 124,906,000 | 4.38% | 0.01% |
| Feb. 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SHARP PHILLIP A | Director | S | Common Stock | 13557 | $151.43 | 270,337.0000 | 124,906,000 | 4.78% | 0.01% |
| Feb. 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SHARP PHILLIP A | Director | S | Common Stock | 915 | $152.40 | 269,422.0000 | 124,906,000 | 0.34% | 0.00% |
| Feb. 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SHARP PHILLIP A | Director | S | Common Stock | 1906 | $153.62 | 267,516.0000 | 124,906,000 | 0.71% | 0.00% |
| Feb. 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SHARP PHILLIP A | Director | S | Common Stock | 101 | $154.07 | 267,415.0000 | 124,906,000 | 0.04% | 0.00% |
| Feb. 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SHARP PHILLIP A | Director | S | Common Stock | 516 | $156.54 | 266,899.0000 | 124,906,000 | 0.19% | 0.00% |
| Feb. 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SHARP PHILLIP A | Director | M | Stock Option (right to buy) | 30000 | $0.00 | 0.0000 | 124,906,000 | 100.00% | 0.02% |
| May 22, 2023 | Vir Biotechnology, Inc. | $VIR | SHARP PHILLIP A | Director | A | Common Stock | 6027 | $0.00 | 254,506.0000 | 0 | 2.43% | 0.00% |
| May 22, 2023 | Vir Biotechnology, Inc. | $VIR | SHARP PHILLIP A | Director | A | Stock Option (Right to Buy) | 12054 | $0.00 | 12,054.0000 | 0 | 9999.99% | 0.00% |